Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
GNPX
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.23
N/A
-6.00
vs -4.40
Q3.23
N/A
-5.20
vs -5.20
Q4.23
N/A
-3.96
vs -0.12
Q1.24
N/A
-3.69
vs -6.00
Q2.24
N/A
-3.00
vs -6.00
Q3.24
N/A
-1.23
vs -5.20
Q4.24
N/A
-1.15
vs -3.96
Q1.25
N/A
-0.26
vs -3.69
Q2.25
N/A
-0.42
vs -3.00
Q3.25
N/A
-0.25
vs -1.23
Sales Growth
YoY
Current
Estimates
Q4.22
NA
NA vs NA
Q1.23
NA
NA vs NA
Q2.23
NA
NA vs NA
Q3.23
NA
NA vs NA
Q4.23
NA
23.2K vs NA
Q1.24
NA
NA vs NA
Q2.24
NA
NA vs NA
Q3.24
NA
NA vs NA
Q4.24
-57%
9.9K vs 23.2K
Q1.25
NA
NA vs NA
Return on Equity
QoQ
Q2.23
-66%
-0.66
vs -0.50
Q3.23
-63%
-0.63
vs -0.66
Q4.23
-80%
-0.80
vs -0.63
Q1.24
-68%
-0.68
vs -0.80
Q2.24
-149%
-1.49
vs -0.68
Q3.24
-259%
-2.59
vs -1.49
Q4.24
-267%
-2.67
vs -2.59
Q1.25
-103%
-1.03
vs -2.67
Institutionnal Ownership
QoQ
Q2.23
39
39
vs 40
-2%
Q3.23
38
38
vs 39
-3%
Q4.23
33
33
vs 38
-13%
Q1.24
15
15
vs 33
-55%
Q2.24
14
14
vs 15
-7%
Q3.24
20
20
vs 14
43%
Q4.24
22
22
vs 20
10%
Q1.25
23
23
vs 22
5%
prnewswire.com
7 hours ago
Relative Strength
GNPX
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
-342%2026-EPS
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.
NASDAQ
Unprofitable
EPS improving
Unprofitable
EPS improving
0.00Â ( 1.12%)
Relative Strenght
3
Volume Buzz
-59%
Earning Acce
Yes
Dist 52w H.
93%Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How GNPX compares to sector?
GNPX
0x
